$Cytek Biosciences (CTKB.US)$After listing in 2021, revenue ...

逍遥投资派 commented on a stock · May 30, 2023 11:31

$Cytek Biosciences(CTKB.US)$After listing in 2021, revenue continued to grow rapidly, and operating profit declined sharply. 2022 entered a loss range. Net profit was slightly affected by interest income.

2023Q1 revenue increased 5.8%, operating profit loss increased 4.2 times, net profit turned into loss. Currently, no investment value is visible.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

See Original

Report

2648 Views

Comment

逍遥投资派

486Followers

32Following

2777Visitors